(Bloomberg) -- Life-sciences company Danaher Corp. has stopped pursuing Catalent Inc. after expressing interest in buying the contract manufacturer, according to people familiar with the matter.
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want ...
Life-sciences company Danaher Corporation (NYSE: DHR) is reportedly no longer considering a takeover of contract manufacturer Catalent Inc (NYSE: CTLT) after expressing interest in buying the ...
Days later, Bloomberg reported that Danaher Corp. was no longer considering a takeover of Catalent, according to people familiar with the situation. Danaher had earlier made overtures to the ...
See: Catalent stock rockets 21% premarket on report of takeover interest from Danaher And that’s not all. Catalent also saw higher-than-expected costs at a drug product and drug substance ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want ...
Last month, Bloomberg reported that Danaher had shelved this buyout plan after Catalent announced that it was facing productivity problems and high-than-expected costs at three of its major ...
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...
